Haemonetics
256 hedge funds and large institutions have $6.15B invested in Haemonetics in 2019 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 71 increasing their positions, 103 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
2% less funds holding
Funds holding: 260 → 256 (-4)
31% less repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 103
50% less call options, than puts
Call options by funds: $1.07M | Put options by funds: $2.13M
Holders
256
Holding in Top 10
2
Calls
$1.07M
Puts
$2.13M
Top Buyers
| 1 | +$137M | |
| 2 | +$92.5M | |
| 3 | +$91.1M | |
| 4 |
Neuberger Berman Group
New York
|
+$66.7M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$50.6M |
Top Sellers
| 1 | -$121M | |
| 2 | -$62.5M | |
| 3 | -$49.2M | |
| 4 |
BlackRock
New York
|
-$46.5M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$37.1M |